Institutional investors purchased a net $1.3 million shares of GHDX during the quarter ended September 2014 and now own 93.32% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
NORTH TIDE CAPITAL LLC Bought 1.2 Million shares of Genomic Health Inc
BAILLIE GIFFORD & CO. Bought 470.1 Thousand shares of Genomic Health Inc
DISCOVERY GROUP I LLC Bought 291.3 Thousand shares of Genomic Health Inc